Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M50,979Revenue $M104,099Net Margin (%)1.8Z-Score3.1
Enterprise Value $M62,920EPS $2.3Operating Margin %3.4F-Score5
P/E(ttm))29.7Cash Flow Per Share $3.6Pre-tax Margin (%)2.9Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %25.9Quick Ratio0.5Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %24.3Current Ratio0.6Lower Leverage y-yY
Price/Cash Flow14.9y-y EBITDA Growth Rate %9.2ROA % (ttm)3.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)8.5Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M774ROI % (ttm)3.5Gross Margin Increase y-yN

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXVanguard Health Care Fund 2014-03-31 Buy 0.69%$69.84 - $78.64
($74.72)
$ 66.35-11%New holding, 3265000 sh.3,265,000
ESRXDodge & Cox 2014-03-31 Add0.46%$69.84 - $78.64
($74.73)
$ 66.35-11%Add 106.54%11,586,300
ESRXMario Gabelli 2014-03-31 Add0.05%$69.84 - $78.64
($74.73)
$ 66.35-11%Add 60.44%316,403
ESRXGlenn Greenberg 2014-03-31 Reduce-1.19%$69.84 - $78.64
($74.73)
$ 66.35-11%Reduce -10.42%3,546,006
ESRXRay Dalio 2014-03-31 Reduce-0.02%$69.84 - $78.64
($74.73)
$ 66.35-11%Reduce -30%99,888
ESRXGlenn Greenberg 2013-12-31 Add1.67%$60.88 - $70.6
($65.26)
$ 66.352%Add 17.2%3,958,387
ESRXScott Black 2013-12-31 Add0.74%$60.88 - $70.6
($65.26)
$ 66.352%Add 130.81%173,883
ESRXWallace Weitz 2013-12-31 Add0.48%$60.88 - $70.6
($65.26)
$ 66.352%Add 20.62%1,184,825
ESRXDodge & Cox 2013-12-31 Buy 0.41%$60.88 - $70.6
($65.26)
$ 66.352%New holding, 5609705 sh.5,609,705
ESRXMario Gabelli 2013-12-31 Add0.01%$60.88 - $70.6
($65.26)
$ 66.352%Add 24.35%197,214
ESRXLee Ainslie 2013-12-31 Sold Out -3.5%$60.88 - $70.6
($65.26)
$ 66.352%Sold Out0
ESRXLeon Cooperman 2013-12-31 Reduce-1.64%$60.88 - $70.6
($65.26)
$ 66.352%Reduce -90.9%173,100
ESRXJoel Greenblatt 2013-12-31 Reduce-0.11%$60.88 - $70.6
($65.26)
$ 66.352%Reduce -61.22%34,242
ESRXRay Dalio 2013-12-31 Reduce-0.04%$60.88 - $70.6
($65.26)
$ 66.352%Reduce -34.72%142,688
ESRXLee Ainslie 2013-09-30 Add2.22%$60.94 - $67.66
($64.76)
$ 66.352%Add 173.46%4,184,162
ESRXScott Black 2013-09-30 Buy 0.53%$60.94 - $67.66
($64.76)
$ 66.352%New holding, 75336 sh.75,336
ESRXJoel Greenblatt 2013-09-30 Buy 0.18%$60.94 - $67.66
($64.76)
$ 66.352%New holding, 88295 sh.88,295
ESRXMario Gabelli 2013-09-30 Add0.04%$60.94 - $67.66
($64.76)
$ 66.352%Add 202.84%158,598
ESRXRay Dalio 2013-09-30 Add0.04%$60.94 - $67.66
($64.76)
$ 66.352%Add 62.78%218,588
ESRXGlenn Greenberg 2013-09-30 Reduce-2.34%$60.94 - $67.66
($64.76)
$ 66.352%Reduce -19.48%3,377,491
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ESRX Vanguard Health Care Fund 2014-03-313,265,0000.420.69New Buy
ESRX Dodge & Cox 2014-03-3111,586,3001.50.89+106.54%
ESRX Mario Gabelli 2014-03-31316,4030.040.13+60.44%
ESRX Wallace Weitz 2014-03-311,210,9050.162.9+2.2%
ESRX Jean-Marie Eveillard 2014-03-311,16800
ESRX Scott Black 2014-03-31167,4140.021.4-3.72%
ESRX John Keeley 2014-03-3132,87900.04-4.11%
ESRX Ruane Cunniff 2014-03-315,65500-5.07%
ESRX Glenn Greenberg 2014-03-313,546,0060.4610.8-10.42%
ESRX Joel Greenblatt 2014-03-3127,97100.03-18.31%
ESRX Leon Cooperman 2014-03-31141,3000.020.14-18.37%
ESRX Ray Dalio 2014-03-3199,8880.010.06-30%
Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAZ GEORGEChairman & CEO 2014-06-13Sell681,508$71.21-6.82view
WENTWORTH TIMOTHY CPresident 2014-05-27Sell105,677$70.47-5.85view
Wimberly GarySr. VP & Ch. Information Off. 2014-03-13Sell44,497$78.41-15.38view
Houston ChristineSr. Vice President, Operations 2014-03-12Sell19,757$78.53-15.51view
IGNACZAK EDWARD BExec. VP, Sales and Mktg 2014-03-11Sell120,247$78.54-15.52view
Norton David ASenior VP, Supply Chain 2014-03-11Sell3,160$79.15-16.17view
Ebling Keith J.Exec. VP and Gen. Counsel 2014-03-11Sell25,721$78.69-15.68view
Miller Steven BSr. VP & Chief Med. Officer 2014-03-10Sell12,664$77.96-14.89view
McNamee PatrickExec. VP and COO 2014-03-10Sell68,425$78.28-15.24view
Ebling Keith J.Exec. VP and Gen. Counsel 2014-03-07Sell295,367$77.29-14.15view

Press Releases about ESRX :

    Quarterly/Annual Reports about ESRX:

    News about ESRX:

    Articles On GuruFocus.com
    Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
    David Rolfe's Wedgewood Partners Q2 2014 Commentary Jul 15 2014 
    Weekly CEO Sells Highlight: Installed Building Products Inc, Express Scripts, Adobe Systems Inc, and Jun 22 2014 
    Wedgewood Partners' David Rolfe's Top Five Stocks May 28 2014 
    Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
    It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 
    Warrior Capital’s Major Sells in Review - VistaPrint, Google, Fiserv, Express Scripts Nov 30 2013 
    Scott Black's Top 5 New Stock Buys Oct 21 2013 
    Richard Perry – Eight Sells in Second Quarter – MGIC Up 505% Aug 24 2013 
    ESRX Has More Upside Potential Than You Might Expect Jul 01 2013 

    More From Our Partners
    Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses Jul 26 2014 - BENZINGA

    More From Other Websites
    Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses Jul 26 2014
    [$$] A "Deathblow," but to Whom? Jul 26 2014
    Traders brace for summer's busiest week Jul 25 2014
    Why Bristol-Myers Squibb Loses Out Against This Rival Jul 25 2014
    Health Services Stocks On The Rise With Help From 3 Stocks Jul 24 2014
    Gilead’s Hepatitis C Drug, Sovaldi, Is on Pace to Become a Blockbuster Jul 23 2014
    A.M. Best Affirms Ratings of Medco Containment Company and Medco Containment Insurance Company of... Jul 23 2014
    China Bribery Probe, Dismal Advair Sales Leave Glaxo Shares Gasping Jul 23 2014
    A Dearth in Innovation for Key Drugs Jul 22 2014
    [video] Ebay, Express Scripts Advantages Demonstrate 'Why Moats Matter' Jul 21 2014
    Does Catamaran Stack Up To Express Scripts? Jul 18 2014
    #PreMarket Primer: Friday, July 18: Tension Between Russia And The West At An All Time High Jul 18 2014
    Sovaldi-$55 billion headache for states Jul 17 2014
    State Governments May Spend $55 Billion on Hepatitis C Medications Jul 17 2014
    State Governments May Spend $55 Billion on Hepatitis C Medications Jul 17 2014
    Express Scripts (ESRX) Is Water-Logged And Getting Wetter Today Jul 16 2014
    [video] Don't confuse bull market with brains: Cooperman Jul 16 2014
    3 Health Services Stocks Nudging The Industry Higher Jul 14 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide